Concentra Group Holdings Parent Inc Receivables Turnover Ratio (CON), from the second quarter 2026 to the second quarter 2025 current and historic results, rankings and more - CSIMarket
CSIMarket
 


Concentra Group Holdings Parent Inc   (NYSE: CON)
    Sector  Healthcare    Industry Healthcare Facilities
   Industry Healthcare Facilities
   Sector  Healthcare
 

Concentra Group Holdings Parent Inc Accounts Receivables Turnover Ratio from the second quarter 2026 to the second quarter 2025

Quarterly Results, Trends, Rankings, Statistics


Concentra Group Holdings Parent Inc 's ability to collect accounts receivable sequentially worsen to 8.07, pointing to a challenging and on top of that deteriorating business climate for the Healthcare Facilities industry. Average collection period, for Concentra Group Holdings Parent Inc 's accounts receivable remained unchanged at 45 days, in the Jun 30 2026 quarter.

If we take a look into Healthcare sector 161 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 1560, from overall ranking in the first quarter 2026 at 1819.

What is Receivable Turnover Ratio?
What is Concentra Group Holdings Parent Inc Selling?


What is Receivable Turnover Ratio?





CON Receivables Turnover Ratio (Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
Y / Y Receivable Change 10.33 % 14.87 % 18.46 % 20.14 % 18.69 %
Y / Y Revenue Change 10.03 % 13.74 % 15.92 % 16.98 % 15.25 %
Receivable Turnover Ratio (TTM) 8.07 8.08 8.11 8.14 8.19
CON's Total Ranking # 1560 # 1819 # 1642 # 1634 # 1624
Accounts Receivable average collection period days 45 45 45 45 45
Seq. Receivable Change 1.12 % 14.97 % -7.55 % 2.66 % 5.28 %
Seq. Revenue Change 6.4 % 5.65 % -5.89 % 4 % 9.99 %


Receivable Turnover Company Ranking
Within: No.
Healthcare Facilities Industry # 22
Healthcare Sector # 162
Overall Market # 1560

Receivable Turnover Ratio Statistics
High Average Low
11.2 8.62 8.08
(Dec 31 2024)   (Mar 31 2026)






Financial Statements
Concentra Group Holdings Parent Inc 's Accounts Receivable $ 300 Millions Visit CON's Balance sheet
Concentra Group Holdings Parent Inc 's Sales TTM $ 2,287 Millions Visit CON's Income Statement
Sources of CON's Revenues Visit CON's Sales by Geography

Other Accounts Receivable Turnover Ratios
Healthcare Facilities Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
CON's Receivable Turnover Ratio versus Healthcare Facilities Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
CON's Growth Rates CON's Roa CON's Inventory Turnover Ratio CON's Dividend Comparisons
CON's Profitability Ratios CON's Roi CON's Asset Turnover Ratio CON's Dividend Growth
CON's Valuation Ratios CON's Roe CON's Financial Strength Ratios CON's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Jun 30 2026 Receivable at quarter ending Jun 30 2026
Hims and Hers Health Inc   19.65 $ 2,578.494  Millions$ 131.228  Millions
Lipocine Inc   18.36 $ 1.569  Millions$ 0.085  Millions
Nrx Pharmaceuticals Inc   17.25 $ 3.394  Millions$ 0.197  Millions
Polomar Health Services, Inc.  17.19 $ 3.172  Millions$ 0.185  Millions
Anika Therapeutics Inc   16.70 $ 121.370  Millions$ 7.266  Millions
Vireo Growth Inc.  16.69 $ 511.706  Millions$ 30.659  Millions
Neuraxis Inc   15.53 $ 5.316  Millions$ 0.342  Millions
Agenus Inc  15.44 $ 132.693  Millions$ 8.595  Millions
Longeveron Inc   15.03 $ 1.187  Millions$ 0.079  Millions
Medicinova Inc   15.02 $ 0.920  Millions$ 0.061  Millions
Dar Bioscience Inc   14.57 $ 1.345  Millions$ 0.092  Millions
Nexgel Inc   14.52 $ 11.810  Millions$ 0.813  Millions
China Pharma Holdings Inc  14.46 $ 3.914  Millions$ 0.271  Millions
Lftd Partners Inc   14.13 $ 35.335  Millions$ 2.500  Millions
Ataibeckley Inc   13.83 $ 4.473  Millions$ 0.324  Millions
Arvinas Inc   13.49 $ 316.700  Millions$ 23.475  Millions
Rosecliff Acquisition Corp I  13.43 $ 16.467  Millions$ 1.226  Millions
Corcept Therapeutics Inc  13.30 $ 830.813  Millions$ 62.477  Millions
Precipio inc   13.25 $ 27.198  Millions$ 2.052  Millions
Chemed Corporation  12.94 $ 2,595.001  Millions$ 200.565  Millions
Qhslab Inc   12.77 $ 3.017  Millions$ 0.236  Millions
Petvivo Holdings Inc   12.34 $ 1.182  Millions$ 0.096  Millions
Alpha Pro Tech Ltd   12.25 $ 62.204  Millions$ 5.077  Millions
Vivos Therapeutics Inc   12.21 $ 21.135  Millions$ 1.731  Millions
Milestone Scientific Inc   11.82 $ 8.855  Millions$ 0.749  Millions
Marpai Inc  11.71 $ 16.635  Millions$ 1.420  Millions
Catheter Precision Inc   11.62 $ 1.915  Millions$ 0.165  Millions
Nrc Health  11.35 $ 139.996  Millions$ 12.337  Millions
Picard Medical Inc   11.34 $ 5.983  Millions$ 0.528  Millions
Veracyte Inc   11.07 $ 544.735  Millions$ 49.194  Millions

Date modified: 2026-09-05T04:26:59+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.